These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 28300012

  • 1. Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis.
    Swann AC, Fava M, Tsai J, Mao Y, Pikalov A, Loebel A.
    CNS Spectr; 2017 Apr; 22(2):228-235. PubMed ID: 28300012
    [Abstract] [Full Text] [Related]

  • 2. Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study.
    Tsai J, Thase ME, Mao Y, Ng-Mak D, Pikalov A, Loebel A.
    CNS Spectr; 2017 Apr; 22(2):236-245. PubMed ID: 28357969
    [Abstract] [Full Text] [Related]

  • 3. Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension.
    Goldberg JF, Ng-Mak D, Siu C, Chuang CC, Rajagopalan K, Loebel A.
    CNS Spectr; 2017 Apr; 22(2):220-227. PubMed ID: 28264739
    [Abstract] [Full Text] [Related]

  • 4. Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.
    McIntyre RS, Cucchiaro J, Pikalov A, Kroger H, Loebel A.
    J Clin Psychiatry; 2015 Apr; 76(4):398-405. PubMed ID: 25844756
    [Abstract] [Full Text] [Related]

  • 5. Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study.
    Suppes T, Silva R, Cucchiaro J, Mao Y, Targum S, Streicher C, Pikalov A, Loebel A.
    Am J Psychiatry; 2016 Apr 01; 173(4):400-7. PubMed ID: 26552942
    [Abstract] [Full Text] [Related]

  • 6. Effect of Lurasidone on Sexual Function in Major Depressive Disorder Patients With Subthreshold Hypomanic Symptoms (Mixed Features): Results From a Placebo-Controlled Trial.
    Clayton AH, Tsai J, Mao Y, Pikalov A, Loebel A.
    J Clin Psychiatry; 2018 Aug 07; 79(5):. PubMed ID: 30086213
    [Abstract] [Full Text] [Related]

  • 7. Major depressive disorder with mixed features and treatment response to lurasidone: A symptom network model.
    Goldberg JF, Siu C, Mao Y, Tsai J, Pikalov A, Calabrese JR, Loebel A.
    J Affect Disord; 2020 Dec 01; 277():1045-1054. PubMed ID: 33065813
    [Abstract] [Full Text] [Related]

  • 8. Lurasidone in post-menopausal females with major depressive disorder with mixed features: Post-hoc analysis of a placebo-controlled trial.
    Sramek J, Loebel A, Murphy M, Mao Y, Pikalov A, Cutler NR.
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug 01; 78():12-17. PubMed ID: 28499900
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies.
    Sajatovic M, Forester BP, Tsai J, Kroger H, Pikalov A, Cucchiaro J, Loebel A.
    J Clin Psychiatry; 2016 Oct 01; 77(10):e1324-e1331. PubMed ID: 27529375
    [Abstract] [Full Text] [Related]

  • 10. Lurasidone Efficacy in Mixed Depressive States: A Comparison of Standard Rating Scales to the Koukopoulos Mixed Depression Rating Scale.
    Vöhringer PA, Sani G, Barroilhet SA, Mao Y, Ghaemi SN.
    J Clin Psychopharmacol; 2020 Oct 01; 40(5):491-494. PubMed ID: 32701901
    [Abstract] [Full Text] [Related]

  • 11. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.
    J Clin Psychiatry; 2009 Oct 01; 70(10):1424-31. PubMed ID: 19906346
    [Abstract] [Full Text] [Related]

  • 12. Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial.
    Singh MK, Pikalov A, Siu C, Tocco M, Loebel A.
    J Child Adolesc Psychopharmacol; 2020 Dec 01; 30(10):590-598. PubMed ID: 32392455
    [Abstract] [Full Text] [Related]

  • 13. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project.
    McIntyre RS, Soczynska JK, Cha DS, Woldeyohannes HO, Dale RS, Alsuwaidan MT, Gallaugher LA, Mansur RB, Muzina DJ, Carvalho A, Kennedy SH.
    J Affect Disord; 2015 Feb 01; 172():259-64. PubMed ID: 25451425
    [Abstract] [Full Text] [Related]

  • 14. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T, Kroger H, Pikalov A, Loebel A.
    J Psychiatr Res; 2016 Jul 01; 78():86-93. PubMed ID: 27089521
    [Abstract] [Full Text] [Related]

  • 15. Lurasidone for the Treatment of Irritability Associated with Autistic Disorder.
    Loebel A, Brams M, Goldman RS, Silva R, Hernandez D, Deng L, Mankoski R, Findling RL.
    J Autism Dev Disord; 2016 Apr 01; 46(4):1153-63. PubMed ID: 26659550
    [Abstract] [Full Text] [Related]

  • 16. Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
    Rajagopalan K, Bacci ED, Ng-Mak D, Wyrwich K, Pikalov A, Loebel A.
    BMC Psychiatry; 2016 May 23; 16():157. PubMed ID: 27215976
    [Abstract] [Full Text] [Related]

  • 17. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N, Mullen J, Paulsson B, Vågerö M.
    J Affect Disord; 2007 May 23; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [Abstract] [Full Text] [Related]

  • 18. Major depressive disorder with subthreshold hypomania (mixed features): Clinical characteristics of patients entered in a multiregional, placebo-controlled study.
    Targum SD, Suppes T, Pendergrass JC, Lee S, Silva R, Cucchiaro J, Loebel A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jul 04; 68():9-14. PubMed ID: 26908089
    [Abstract] [Full Text] [Related]

  • 19. Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials.
    McIntyre RS, Masand PS, Earley W, Patel M.
    J Affect Disord; 2019 Oct 01; 257():600-606. PubMed ID: 31344528
    [Abstract] [Full Text] [Related]

  • 20. Recovery in bipolar depression: Post-hoc analysis of a placebo-controlled lurasidone trial followed by a long-term continuation study.
    Loebel A, Siu C, Rajagopalan K, Pikalov A, Cucchiaro J, Ketter TA.
    J Affect Disord; 2015 Nov 01; 186():376-82. PubMed ID: 26363720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.